D-0399-2025 Class II Ongoing

Recalled by American Regent, Inc. — New Albany, OH

FDA drug recall D-0399-2025 was initiated by American Regent, Inc. on Apr 18, 2025 and is designated Class II. Reason for recall: Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance. The recall status is ongoing. Affected quantity: 7,249 (cartons of 10 x 10 mL vials).

Recall details

Product Type
Drugs
Report Date
May 7, 2025
Initiation Date
Apr 18, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,249 (cartons of 10 x 10 mL vials)

Product description

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC carton: 0517-0735-10 / NDC Vial: 0517-0735-01]

Reason for recall

Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.

Distribution pattern

Nationwide in the USA

Code information

Lots, expiry: Lot 24086N0C0, 7/31/2025; Lot 24076N0C0, Lot 24090N0C0, 8/31/2025, Lot 25011N0C0, 6/30/2026;

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0399-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0399-2025. Report a data issue: hello@regdatalab.com.